References
- DeLorenzo RJ, Hauser WA, Towne AR, et al. A prospective, population-based epidemiologic study of status epilepticus in Richmond, Virginia. Neurology 1996;46:1029-35
- DeLorenzo RJ, Kirmani B, Deshpande LS, et al. Comparisons of the mortality and clinical presentations of status epilepticus in private practice community and university hospital settings in Richmond, Virginia. Seizure 2009;18:405-11
- Dham BS, Hunter K, Rincon F. The epidemiology of status epilepticus in the United States. Neurocrit Care 2014;20:476-83. http://www.ncbi.nlm.nih.gov/pubmed/24519080. Accessed March 31, 2016
- Brophy GM, Bell R, Claassen J, et al. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care 2012;17:3-23
- Shorvon S. Super-refractory status epilepticus: An approach to therapy in this difficult clinical situation. Epilepsia 2011;52(Suppl 8):53-6
- Shorvon S, Ferlisi M. The treatment of super-refractory status epilepticus: A critical review of available therapies and a clinical treatment protocol. Brain 2011;134:2802-18
- Hocker S, Tatum WO, LaRoche S, et al. Refractory and super-refractory status epilepticus - An update. Curr Neurol Neurosci Rep 2014;14: 452
- Li Y, Tian L, Zeng T, et al. Clinical features and outcome of super-refractory status epilepticus: A retrospective analysis in West China. Seizure 2014;23:722-7
- Jayalakshmi S, Ruikar D, Sudhindra Vooturi, et al. Determinants and predictors of outcome in super refractory status epilepticus—A developing country perspective. Epilepsy Res 2014;108:1609-17
- Tian L, Li Y, Xue X, et al. Super-refractory status epilepticus in West China. Acta Neurol Scand 2015;132:1-6
- Trinka E, Shorvon S. Status epilepticus—Where are we in 2013? Epilepsia 2013;54(Suppl 6):1-2
- Shorvon S, Ferlisi M. The outcome of therapies in refractory and super-refractory convulsive status epilepticus and recommendations for therapy. Brain 2012;135:2314-28
- Zeiler FA. Early Use of the NMDA Receptor Antagonist Ketamine in Refractory and Superrefractory Status Epilepticus. Critical Care Research and Practice 2015;2015:5
- Zhumadilov A, Gilman CP and Viderman D. Management of super-refractory status epilepticus with isoflurane and hypothermia. Front. Neurol. 2015;5:286
- Thakur KT, Probasco JC, Hocker SE, et al. Ketogenic diet for adults in super-refractory status epilepticus. Neurology 2014;82:665-70
- Strzelczyk A, Knake S, Oertel WH, et al. Inpatient treatment costs of status epilepticus in adults in Germany. Seizure 2013;22:882-5
- Betjemann JP, Josephson SA, Lowenstein DH, et al. Trends in status epilepticus-related hospitalizations and mortality: Redefined in US practice over time. JAMA Neurol 2015;72:650-5. http://www.ncbi.nlm.nih.gov/pubmed/25915004. Accessed February 1, 2016
- Hesdorffer DC, Logroscino G, Cascino G, et al. Incidence of status epilepticus in Rochester, Minnesota, 1965–1984. Neurology 1998;50:735-41
- Logroscino G, Hesdorffer DC, Cascino G, et al. Time trends in incidence, mortality, and case-fatality after first episode of status epilepticus. Epilepsia 2001;42:1031-5
- Monthly population estimates for the United States: April 1, 2010 to December 1, 2016. US Census Bureau, Population Division. 2015. http://factfinder.census.gov/faces/tableservices/jsf/pages/productview.xhtml?src=bkmk. Accessed June 19, 2016
- Neligan A, Shorvon SD. Frequency and prognosis of convulsive status epilepticus of different causes: a systematic review. Arch Neurol 2010;67:931-40
- Kantanen A-M, Reinikainen M, Parviainen I, et al. Incidence and mortality of super-refractory status epilepticus in adults. Epilepsy Behav 2015;49:131-4
- Giovannini G, Monti G, Polisi MM, et al. A one-year prospective study of refractory status epilepticus in Modena, Italy. Epilepsy Behav 2015;49:141-5
- Novy J, Logroscino G, Rossetti AO. Refractory status epilepticus: A prospective observational study. Epilepsia 2010;51:251-6
- Mayer SA, Claassen J, Lokin J, et al. Refractory status epilepticus: frequency, risk factors, and impact on outcome. Arch Neurol 2002;59:205-10
- Rossetti AO, Logroscino G, Bromfield EB. Refractory status epilepticus. Arch Neurol 2005;62:1698-702
- Premier Research Services. https://www.premierinc.com/transforming-healthcare/healthcare-performance-improvement/premier-research-services/. Accessed June 30, 2016
- Holtkamp M, Othman J, Buchheim K, et al. Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit. J Neurol Neurosurg Psychiatry 2005;76:534-9
- Gizerian SS. Neurosteroids in cortical development and the etiology of schizophrenia. In Neuroactive Steroids in Brain Function, Behavior and Neuropsychiatric Disorders: Novel Strategies for Research and Treatment. 2008. p. 299 -324
- Schreiber JM, Gaillard WD. Treatment of refractory status epilepticus in childhood. Curr Neurol Neurosci Rep 2011;11:195-204
- Health care institutions-Types of hospitals. Library Index. 2016. http://www.libraryindex.com/pages/1831/Health-Care-Institutions-TYPES-HOSPITALS.html. Accessed June 6, 2016
- Penberthy LT, Towne A, Garnett LK, et al. Estimating the economic burden of status epilepticus to the health care system. Seizure 2005;14:46-51
- Jette N, Beghi E, Hesdorffer D, et al. ICD coding for epilepsy: past, present, and future—a report by the International League Against Epilepsy Task Force on ICD codes in epilepsy. Epilepsia 2015;56:348-55
- Fillit H, Geldmacher DS, Welter RT, et al. Optimizing coding and reimbursement to improve management of Alzheimer’s disease and related dementias. J Am Geriatr Soc 2002;50:1871-8
- Labar DR, Fisch BJ, Pedley TA, et al. Quantitative EEG monitoring for patients with subarachnoid hemorrhage. Electroencephalogr Clin Neurophysiol 1991;78:325-32
- Claassen J, Hirsch LJ, Kreiter KT, et al. Quantitative continuous EEG for detecting delayed cerebral ischemia in patients with poor-grade subarachnoid hemorrhage. Clin Neurophysiol 2004;115:2699-710
- Friedman D, Claassen J, Hirsch LJ. Continuous electroencephalogram monitoring in the intensive care unit. Anesth Analg 2009;109:506-23
- Thurman DJ, Beghi E, Begley CE, et al. Standards for epidemiologic studies and surveillance of epilepsy. Epilepsia 2011;52(Suppl 7):2-26
- Reid AY, St. Germaine-Smith C, Liu M, et al. Development and validation of a case definition for epilepsy for use with administrative health data. Epilepsy Res 2012;102:173-9
- St. Germaine-Smith C, Metcalfe A, Pringsheim T, et al. Recommendations for optimal ICD codes to study neurologic conditions: a systematic review. Neurology 2012;79:1049-55
- Walker AM. Pattern recognition in health insurance claims databases. Pharmacoepidemiol Drug Saf 10:393-7. http://www.ncbi.nlm.nih.gov/pubmed/11802583. Accessed June 6, 2016
- Pugin D, Foreman B, De Marchis GM, et al. Is pentobarbital safe and efficacious in the treatment of super-refractory status epilepticus: a cohort study. Crit Care 2014;18:R103
- Cooper AD, Britton JW, Rabinstein AA. Functional and cognitive outcome in prolonged refractory status epilepticus. Arch Neurol 2009;66:1505-9
- Kortland LM, Knake S, Rosenow F, et al. Cost of status epilepticus: A systematic review. Seizure 2015;24:17-20
- Franchi C, Giussani G, Messina P, et al. Validation of healthcare administrative data for the diagnosis of epilepsy. J Epidemiol Community Health 2013;67:1019-24
- Bakaki PM, Koroukian SM, Jackson LW, et al. Defining incident cases of epilepsy in administrative data. Epilepsy Res 2013;106:273-9
- Christensen J, Vestergaard M, Olsen J, et al. Validation of epilepsy diagnoses in the Danish National Hospital Register. Epilepsy Res 2007;75:162-70
- Christensen J, Vestergaard M, Pedersen MG, et al. Incidence and prevalence of epilepsy in Denmark. Epilepsy Res 2007;76:60-5
- Tu K, Wang M, Jaakkimainen RL, et al. Assessing the validity of using administrative data to identify patients with epilepsy. Epilepsia 2014;55:335-43
- Faught E, Richman J, Martin R, et al. Incidence and prevalence of epilepsy among older US Medicare beneficiaries. Neurology 2012;78:448-53
- Tan M, Wilson I, Braganza V, et al. Development and validation of an epidemiologic case definition of epilepsy for use with routinely collected Australian health data. Epilepsy Behav 2015;51:65-72
- McWilliams JM, Landon BE, Chernew ME. Changes in health care spending and quality for Medicare beneficiaries associated with a commercial ACO contract. JAMA 2013;310:829-836. http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3860102&tool=pmcentrez&rendertype=abstract. Accessed May 20, 2016
- Logroscino G, Hesdorffer DC, Cascino G, et al. Mortality after a first episode of status epilepticus in the United States and Europe. Epilepsia 2005;46(Suppl. 11):46-8